DK33190A - Hiv-3 retrovirus og anvendelse heraf - Google Patents
Hiv-3 retrovirus og anvendelse heraf Download PDFInfo
- Publication number
- DK33190A DK33190A DK033190A DK33190A DK33190A DK 33190 A DK33190 A DK 33190A DK 033190 A DK033190 A DK 033190A DK 33190 A DK33190 A DK 33190A DK 33190 A DK33190 A DK 33190A
- Authority
- DK
- Denmark
- Prior art keywords
- hiv
- retrovirus
- nucleic acid
- acid sequence
- region
- Prior art date
Links
- 206010020164 HIV infection CDC Group III Diseases 0.000 title abstract 6
- 241001430294 unidentified retrovirus Species 0.000 title abstract 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 101800001690 Transmembrane protein gp41 Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 101710121417 Envelope glycoprotein Proteins 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
- Y10S530/809—Fused cells, e.g. hybridoma
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP88109200 | 1988-06-09 | ||
EP88109200A EP0345375B1 (en) | 1988-06-09 | 1988-06-09 | HIV-3 retrovirus and its use |
PCT/EP1989/000643 WO1989012094A1 (en) | 1988-06-09 | 1989-06-08 | Hiv-3 retrovirus and its use |
EP8900643 | 1989-06-08 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK33190D0 DK33190D0 (da) | 1990-02-08 |
DK33190A true DK33190A (da) | 1990-03-28 |
DK176078B1 DK176078B1 (da) | 2006-04-10 |
Family
ID=8199044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK199000331A DK176078B1 (da) | 1988-06-09 | 1990-02-08 | HIV-3 retrovirus og anvendelse heraf |
Country Status (10)
Country | Link |
---|---|
US (7) | US5304466A (da) |
EP (3) | EP1369427A3 (da) |
JP (1) | JP2882654B2 (da) |
AT (1) | ATE120234T1 (da) |
AU (1) | AU625970B2 (da) |
CY (1) | CY2051B1 (da) |
DE (1) | DE3853422T2 (da) |
DK (1) | DK176078B1 (da) |
ES (1) | ES2072853T3 (da) |
WO (1) | WO1989012094A1 (da) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364933A (en) | 1986-03-03 | 1994-11-15 | Institut Pasteur | Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2) |
EP1369427A3 (en) * | 1988-06-09 | 2004-05-12 | Innogenetics N.V. | HIV-3 retrovirus strains and their use |
ES2053014T5 (es) * | 1990-06-15 | 2001-02-16 | Innogenetics Nv | El retrovirus sivcpz-ant y sus usos. |
US6709828B1 (en) | 1992-03-06 | 2004-03-23 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
ATE364621T1 (de) | 1992-03-06 | 2007-07-15 | Innogenetics Nv | Hiv-peptide |
US6667387B1 (en) | 1996-09-30 | 2003-12-23 | N.V. Innogenetics S.A. | HCV core peptides |
ATE174382T1 (de) * | 1992-10-06 | 1998-12-15 | Dade Behring Marburg Gmbh | Retrovirus aus der hiv-gruppe und dessen verwendung |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
GB9410044D0 (en) * | 1994-05-19 | 1994-07-06 | Int Murex Tech Corp | Assay |
DK0787191T4 (da) | 1994-10-20 | 2012-01-30 | Pasteur Institut | Nukleotidsekvenser af HIV-1 type (eller undertype) O retrovirusantigener |
US5599662A (en) * | 1995-02-17 | 1997-02-04 | Hoffmann-La Roche Inc. | Oliconucleotide primers and probes for the detection of HIV-1 |
WO1996040763A2 (en) * | 1995-06-07 | 1996-12-19 | Abbott Laboratories | Peptides for hiv-1 detection |
US5612473A (en) * | 1996-01-16 | 1997-03-18 | Gull Laboratories | Methods, kits and solutions for preparing sample material for nucleic acid amplification |
AU6727798A (en) † | 1997-03-10 | 1998-09-29 | Roche Diagnostics Gmbh | Method for simultaneous detection of hiv antigens and hiv antibodies |
US5922533A (en) * | 1997-08-15 | 1999-07-13 | Abbott Laboratories | Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups |
US6846905B2 (en) * | 1997-08-15 | 2005-01-25 | Abbott Laboratories | Antigen constructs useful in the detection and differentiation of antibodies to HIV |
US7244570B2 (en) | 1998-08-04 | 2007-07-17 | Luminex Molecular Diagnostics, Inc. | Methods and compositions for modulating “marginally indiscriminant” hybridizations |
US6235479B1 (en) | 1999-04-13 | 2001-05-22 | Bio Merieux, Inc. | Methods and devices for performing analysis of a nucleic acid sample |
US6623920B1 (en) * | 1999-07-09 | 2003-09-23 | Gen-Probe Incorporated | Detection of HIV-1 by nucleic acid amplification |
CN1423698A (zh) | 1999-11-16 | 2003-06-11 | 真那特应用生物科技有限公司 | Hiv-1亚型间(c/b’)基因组和其用途 |
US6582920B2 (en) | 2000-09-01 | 2003-06-24 | Gen-Probe Incorporated | Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations |
US6818392B2 (en) | 2000-12-06 | 2004-11-16 | Abbott Laboratories | Monoclonal antibodies to human immunodeficiency virus and uses thereof |
US20030175950A1 (en) * | 2001-05-29 | 2003-09-18 | Mcswiggen James A. | RNA interference mediated inhibition of HIV gene expression using short interfering RNA |
AU2003229455A1 (en) * | 2002-05-16 | 2003-12-02 | Medmira Inc. | Rapid vaccinia antibody detection device, method and test kit |
US20050214318A1 (en) * | 2003-10-23 | 2005-09-29 | Nmk Research, Llc | Immunogenic composition and method of developing a vaccine based on fusion protein |
WO2009053967A1 (en) * | 2007-10-22 | 2009-04-30 | Amorphical Ltd. | Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins |
CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
SI2691530T1 (en) | 2011-06-10 | 2018-08-31 | Oregon Health & Science University | CMV glycoproteins and recombinant vectors |
US20130189754A1 (en) | 2011-09-12 | 2013-07-25 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
EP2586461A1 (en) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Viral particles derived from an enveloped virus |
ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
EP2848937A1 (en) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Methods of identifying novel HIV-1 immunogens |
US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
EP3072901A1 (en) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
US11052107B2 (en) | 2015-06-04 | 2021-07-06 | Amorphical Ltd. | Amorphous calcium carbonate stabilized with polyphosphates or bisphosphonates |
EP3532074B1 (en) | 2016-10-25 | 2023-08-23 | Amorphical Ltd. | Amorphous calcium carbonate for use in a method of treating a leukemia |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5217861A (en) * | 1983-09-15 | 1993-06-08 | Institut Pasteur | Antigen of a human retrovirus, namely p18 protein of human immunodeficiency virus (HIV), compositions containing the antigen, a diagnostic method for detecting acquired immune deficiency syndrome (AIDS) and pre-AIDS and a kit therefor |
IE64006B1 (en) * | 1984-10-18 | 1995-06-28 | Pasteur Institut | Antigens particulary envelope antigens of the virus of lymphadenopathies and of the acquired immune-deficiency syndrome and virus process for producing virus envelope antigens use of said antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus |
ATE195148T1 (de) * | 1986-01-22 | 2000-08-15 | Pasteur Institut | Prozess zur rekombinanten herstellung von hiv-2 - proteinen sowie zellen, die hiv-2 - proteine exprimiert |
US5066782A (en) * | 1986-01-22 | 1991-11-19 | Institut Pasteur | Retrovirus capable of causing AIDS, means and method for detecting it in vitro |
US4839288A (en) * | 1986-01-22 | 1989-06-13 | Institut Pasteur | Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
US5030714A (en) * | 1986-06-23 | 1991-07-09 | Institut Pasteur | Variant of LAV viruses |
US5166050A (en) * | 1986-08-20 | 1992-11-24 | Bristol-Myers Squibb Company | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections |
SE8701765L (sv) * | 1987-04-28 | 1988-10-29 | Statens Bakteriologiska Lab | Analysmetod och medel foer denna |
EP1369427A3 (en) * | 1988-06-09 | 2004-05-12 | Innogenetics N.V. | HIV-3 retrovirus strains and their use |
-
1988
- 1988-06-09 EP EP03008364A patent/EP1369427A3/en not_active Withdrawn
- 1988-06-09 EP EP88109200A patent/EP0345375B1/en not_active Expired - Lifetime
- 1988-06-09 DE DE3853422T patent/DE3853422T2/de not_active Expired - Lifetime
- 1988-06-09 ES ES88109200T patent/ES2072853T3/es not_active Expired - Lifetime
- 1988-06-09 EP EP94110658A patent/EP0657532B1/en not_active Revoked
- 1988-06-09 AT AT88109200T patent/ATE120234T1/de not_active IP Right Cessation
-
1989
- 1989-06-08 JP JP1506144A patent/JP2882654B2/ja not_active Expired - Lifetime
- 1989-06-08 AU AU37628/89A patent/AU625970B2/en not_active Expired
- 1989-06-08 WO PCT/EP1989/000643 patent/WO1989012094A1/en unknown
- 1989-06-08 US US07/460,913 patent/US5304466A/en not_active Expired - Lifetime
-
1990
- 1990-02-08 DK DK199000331A patent/DK176078B1/da not_active IP Right Cessation
-
1994
- 1994-04-15 US US08/228,519 patent/US5567603A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/486,836 patent/US5795743A/en not_active Expired - Lifetime
- 1995-06-07 US US08/474,360 patent/US5858647A/en not_active Expired - Lifetime
-
1997
- 1997-07-25 US US08/900,902 patent/US6013484A/en not_active Expired - Lifetime
-
1998
- 1998-04-30 CY CY9802051A patent/CY2051B1/xx unknown
-
1999
- 1999-08-23 US US09/379,270 patent/US6265200B1/en not_active Expired - Fee Related
-
2001
- 2001-05-09 US US09/851,664 patent/US20030039954A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US5304466A (en) | 1994-04-19 |
US6013484A (en) | 2000-01-11 |
ATE120234T1 (de) | 1995-04-15 |
WO1989012094A1 (en) | 1989-12-14 |
ES2072853T3 (es) | 1995-08-01 |
AU625970B2 (en) | 1992-07-23 |
EP1369427A2 (en) | 2003-12-10 |
US6265200B1 (en) | 2001-07-24 |
JP2882654B2 (ja) | 1999-04-12 |
JPH02504583A (ja) | 1990-12-27 |
EP0657532B1 (en) | 2003-12-17 |
DK176078B1 (da) | 2006-04-10 |
EP0657532A1 (en) | 1995-06-14 |
AU3762889A (en) | 1990-01-05 |
US5858647A (en) | 1999-01-12 |
EP0345375A1 (en) | 1989-12-13 |
DE3853422D1 (de) | 1995-04-27 |
CY2051B1 (en) | 1998-04-30 |
EP1369427A3 (en) | 2004-05-12 |
EP0345375B1 (en) | 1995-03-22 |
DK33190D0 (da) | 1990-02-08 |
US5795743A (en) | 1998-08-18 |
US20030039954A1 (en) | 2003-02-27 |
US5567603A (en) | 1996-10-22 |
DE3853422T2 (de) | 1995-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK33190A (da) | Hiv-3 retrovirus og anvendelse heraf | |
Salminen et al. | Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C | |
Cafaro et al. | Control of SHIV-89.6 P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine | |
NO921969L (no) | Ikke-replikerende rekombinant fremstilte retroviruspartikler brukt som antivirale midler og immunogener | |
DE69535757D1 (de) | Rekombinanter immunschwächepoxvirus | |
DK513388D0 (da) | Peptider med immunologiske egenskaber svarende til hiv-2 virus, nucleotidsekvenser, der koder for saadanne peptider, antigene og immunogene midler indeholdende saadanne peptider samt fremgangsmaade og kit til in vitro diagnose af hiv-2 | |
KR970701782A (ko) | 생체내에서 유전자의 통합성 발현(Coordinate in vivo gene expression) | |
NO863803L (no) | Vaksiner og immunoanalyser for ervervet immunsviktsyndrom (aids). | |
WO1990015066A3 (fr) | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus | |
ATE362379T1 (de) | Induktion rev- und tat-spezifischer zytotoxischer t-zellen zur prävention und behandlung einer infektion durch humanen immundefizienz-virus (hiv) | |
EP0278940A3 (en) | Hepatitis b virus surface antigens and hybrid antigens containing them | |
JP2001527029A5 (da) | ||
EP0342860A3 (en) | Novel protein, sequences containing the gene therefore, vectors, methods of preparation and use | |
DE3855134D1 (de) | Monoklonale menschliche antikörper gegen hiv-i | |
DE60026199T2 (de) | Synthetische Gene für gagpol und deren Verwendungen | |
DK0946731T3 (da) | Ikke-M, ikke O HIV-1 stammer, fragmenter og anvendelser | |
Hejdeman et al. | DNA immunization with HIV early genes in HIV type 1-infected patients on highly active antiretroviral therapy | |
Matthews et al. | Prospects for development of a vaccine against HTLV-III-related disorders | |
US7713530B2 (en) | HIV-1 subtype isolate regulatory/accessory genes, and modification and derivatives thereof | |
KR900702045A (ko) | 천연 hiv gp 160의 제조방법 | |
MY104530A (en) | Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for pro- phylaxis and therapy against human retroviruses. | |
CA2408786A1 (en) | Retroviral vectors comprising an enhanced 3' transcription termination structure | |
Blancou et al. | Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus | |
DK0592636T3 (da) | Fremgangsmåde til fremstilling af en levedygtig cellekultur, der er inficeret med en med dissemineret sklerose forbundet vi | |
EP1309617B1 (en) | Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |